Last reviewed · How we verify
NCT05462080: COMMAND
Correlation of Motor Metrics and Neurological Data
trial testing Ceraxis product in Movement Disorders (Incl Parkinsonism) in 29 participants. Completed in 31 August 2023.
31 August 2023
Quick facts
| Lead sponsor | Ceraxis Health, Inc |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 29 |
| Start date | 10 November 2022 |
| Primary completion | 31 August 2023 |
| Estimated completion | 31 August 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Ceraxis product
Conditions studied
- Movement Disorders (Incl Parkinsonism) — all drugs for Movement Disorders (Incl Parkinsonism) →
Sponsor
Ceraxis Health, Inc
Who can join
21 and older, any sex, with Movement Disorders (Incl Parkinsonism). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a pilot study to collect data with the Ceraxis product and standard movement disorders tests in order to prove and codify potential correlations.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05462080
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Movement Disorders (Incl Parkinsonism)
Currently open trials in the same condition.
- NCT07056361 — Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control · NA · recruiting
- NCT07056348 — Long-term Brain Stimulation of the Motor Ventral Thalamus (VOP/VIM) to Improve Motor Function · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05462080 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ceraxis Health, Inc
- Last refreshed: 20 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05462080.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing